Skip to main content
Have a personal or library account? Click to login
Does dehydroepiandrosterone sulfate have a role in COVID-19 prognosis and treatment? Cover

Does dehydroepiandrosterone sulfate have a role in COVID-19 prognosis and treatment?

Endocrine Regulations
Volume 55 (2021): Issue 3 (July 2021)
By: ,  ,   and    
Open Access
|Sep 2021
Authors

Authors

Sojit Tomo

Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India

Mithu Banerjee

mithu.banerjee.3@gmail.com

Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India

Praveen Sharma

Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India

Mahendra Garg

Department of Medicine, All India Institute of Medical Sciences, Jodhpur, India
DOI: https://doi.org/10.2478/enr-2021-0019 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Journal RSS Feed
Language: English
Page range: 174 - 181
Published on: Sep 13, 2021
Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
COVID-19,
hypothalamic-pituitary-adrenal axis,
DHEA,
DHEAS,
cortisol
Related subjects:
Life sciences,
Molecular biology,
Neurobiology,
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Internal medicine,
Endocrinology, diabetology

© 2021 Sojit Tomo, Mithu Banerjee, Praveen Sharma, Mahendra Garg, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 55 (2021): Issue 3 (July 2021)
Previous article
Next article